Bioreactor recombinant production of SARS-CoV-2 virus antigens in cho cell clones by using new ucoe lentiviral vector system
| dc.authorid | 0000-0002-5747-9644 | en_US |
| dc.authorid | 0000-0003-1334-1050 | en_US |
| dc.contributor.author | Anakök, Ömer Faruk | |
| dc.contributor.author | Köse, Pınar | |
| dc.date.accessioned | 2024-07-03T13:11:22Z | |
| dc.date.available | 2024-07-03T13:11:22Z | |
| dc.date.issued | 2023 | en_US |
| dc.department | BAİBÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
| dc.description.abstract | Background & Aim: The new UCOE models we have recently developed, tested on many cell groups (including mouse ES and human iPS cells) and human mAb recombinant production studies as well, shows a powerful resistance to DNA methylation- mediated silencing and provides a higher and stable transfection profile. By the urgent need of vaccine development for COVID-19 during the pandemic, in this study we aimed to produce a potential recombinant vaccine by using the new generation UCOEs models of our own design | en_US |
| dc.identifier.citation | Anakok, O. F., Kose, P., & Bayindirli, K. N. (2023). Gene Editing/Gene Therapies: BIOREACTOR RECOMBINANT PRODUCTION OF SARS-COV-2 VIRUS ANTIGENS IN CHO CELL CLONES BY USING NEW UCOE LENTIVIRAL VECTOR SYSTEM. Cytotherapy, 25(6), S258. | en_US |
| dc.identifier.endpage | S259 | en_US |
| dc.identifier.issn | 1465-3249 | |
| dc.identifier.issn | 1477-2566 | |
| dc.identifier.issue | 6 | en_US |
| dc.identifier.startpage | S258 | en_US |
| dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171031/ | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12491/12238 | |
| dc.identifier.volume | 25 | en_US |
| dc.identifier.wos | WOS:001041036100524 | en_US |
| dc.identifier.wosquality | Q1 | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.institutionauthor | Bayındırlı, Kübra Nur | |
| dc.institutionauthor | Anakök, Ömer Faruk | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science Ltd | en_US |
| dc.relation.ispartof | Cytotherapy | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - İdari Personel ve Öğrenci | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | UCOE | en_US |
| dc.subject | Recombinant Vaccine | en_US |
| dc.title | Bioreactor recombinant production of SARS-CoV-2 virus antigens in cho cell clones by using new ucoe lentiviral vector system | en_US |
| dc.type | Conference Object | en_US |
